Differential sensitivity to short-chain ceramide analogues of human intestinal carcinoma cells grown in tumor spheroids versus monolayer culture
- PMID: 14640787
- DOI: 10.1290/1543-706X(2003)039<0340:DSTSCA>2.0.CO;2
Differential sensitivity to short-chain ceramide analogues of human intestinal carcinoma cells grown in tumor spheroids versus monolayer culture
Abstract
The cytotoxic activity of short-chain (C(2)) ceramide was evaluated in human intestinal carcinoma cells grown as multicellular tumor spheroids versus the same cells cultured as monolayers under closely comparable conditions. A decrease in cell number was seen in monolayer cultures of HT-29, Caco-2, and HRT-18 cells, with an EC(50) (concentration for half-maximal toxicity) of between 13 and 23 microM. However, when the same cells were grown in the multicellular spheroid format, C(2) was markedly less potent in reducing cell number, with an EC(50) of between 44 and 63 microM, representing a 1.9- to 4.9-fold decrease in its potency. The chemotherapeutic agents 5-fluorouracil and cisplatin were equally potent against spheroids and monolayer cultures, indicating that although drug access is a problem in conventionally grown tumor spheroids it is not a problem for spheroids grown under the conditions used in this study. Our results suggest that although ceramide is capable of inducing cell death in intestinal carcinoma cells grown in spheroid culture, its cellular toxicity is constrained by influences that are independent of drug access and may be the consequence of the altered cellular relationships. Carcinoma cell populations show an intrinsically decreased responsiveness to the effects of ceramide when they are grown in a three-dimensional culture format.
Similar articles
-
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.Clin Cancer Res. 2000 Sep;6(9):3719-28. Clin Cancer Res. 2000. PMID: 10999766
-
Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.Cancer Res. 1997 Jun 15;57(12):2388-93. Cancer Res. 1997. PMID: 9192815
-
Efficacy of a polyurethane foam/spheroid artificial liver by using human hepatoblastoma cell line (Hep G2).Cell Transplant. 2003;12(1):51-8. doi: 10.3727/000000003783985151. Cell Transplant. 2003. PMID: 12693664
-
Recent advances in three-dimensional multicellular spheroid culture for biomedical research.Biotechnol J. 2008 Oct;3(9-10):1172-84. doi: 10.1002/biot.200700228. Biotechnol J. 2008. PMID: 18566957 Review.
-
Three-dimensional spheroid model in tumor biology.Pathobiology. 1999 May-Jun;67(3):148-57. doi: 10.1159/000028065. Pathobiology. 1999. PMID: 10394136 Review.
Cited by
-
In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.PLoS One. 2017 Nov 15;12(11):e0188100. doi: 10.1371/journal.pone.0188100. eCollection 2017. PLoS One. 2017. PMID: 29141026 Free PMC article.
-
Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?Front Pharmacol. 2021 May 18;12:681477. doi: 10.3389/fphar.2021.681477. eCollection 2021. Front Pharmacol. 2021. PMID: 34084146 Free PMC article. Review.
-
EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.Front Immunol. 2022 Dec 16;13:957233. doi: 10.3389/fimmu.2022.957233. eCollection 2022. Front Immunol. 2022. PMID: 36591314 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous